The Manufacturers Life Insurance Company lifted its stake in shares of ICU Medical, Incorporated (NASDAQ:ICUI) by 2.2% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 11,603 shares of the medical instruments supplier’s stock after purchasing an additional 245 shares during the quarter. The Manufacturers Life Insurance Company owned about 0.06% of ICU Medical worth $2,505,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other institutional investors and hedge funds have also bought and sold shares of ICUI. Exane Derivatives acquired a new stake in ICU Medical in the 4th quarter valued at approximately $100,000. Eagle Boston Investment Management Inc. acquired a new stake in ICU Medical in the 3rd quarter valued at approximately $200,000. Raymond James Trust N.A. acquired a new stake in ICU Medical in the 4th quarter valued at approximately $204,000. Zurcher Kantonalbank Zurich Cantonalbank increased its position in ICU Medical by 39.2% in the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 984 shares of the medical instruments supplier’s stock valued at $213,000 after acquiring an additional 277 shares during the period. Finally, LS Investment Advisors LLC increased its position in ICU Medical by 98.3% in the 4th quarter. LS Investment Advisors LLC now owns 1,142 shares of the medical instruments supplier’s stock valued at $247,000 after acquiring an additional 566 shares during the period. Hedge funds and other institutional investors own 77.25% of the company’s stock.
Shares of ICU Medical, Incorporated (NASDAQ:ICUI) opened at $253.55 on Thursday. ICU Medical, Incorporated has a 1 year low of $144.25 and a 1 year high of $265.27. The company has a debt-to-equity ratio of 0.07, a current ratio of 4.65 and a quick ratio of 3.01. The company has a market capitalization of $5,140.33, a P/E ratio of 54.21, a P/E/G ratio of 2.57 and a beta of 0.42.
ICU Medical (NASDAQ:ICUI) last posted its earnings results on Thursday, March 1st. The medical instruments supplier reported $2.98 EPS for the quarter, beating the consensus estimate of $1.04 by $1.94. The firm had revenue of $370.12 million for the quarter, compared to analysts’ expectations of $332.91 million. ICU Medical had a return on equity of 8.54% and a net margin of 5.31%. The firm’s revenue was up 286.8% compared to the same quarter last year. During the same period last year, the firm earned $1.20 EPS. equities analysts anticipate that ICU Medical, Incorporated will post 6.29 earnings per share for the current year.
Several research firms recently commented on ICUI. BidaskClub upgraded ICU Medical from a “hold” rating to a “buy” rating in a research report on Wednesday, March 7th. Zacks Investment Research upgraded ICU Medical from a “hold” rating to a “buy” rating and set a $266.00 target price on the stock in a research report on Tuesday, January 23rd. Two research analysts have rated the stock with a hold rating and three have given a buy rating to the stock. The company presently has a consensus rating of “Buy” and a consensus price target of $266.00.
In other ICU Medical news, Director Robert S. Swinney sold 724 shares of the stock in a transaction on Friday, January 19th. The stock was sold at an average price of $235.00, for a total transaction of $170,140.00. Following the completion of the transaction, the director now directly owns 14,830 shares of the company’s stock, valued at approximately $3,485,050. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CFO Scott E. Lamb sold 23,624 shares of the stock in a transaction on Thursday, January 4th. The shares were sold at an average price of $220.00, for a total value of $5,197,280.00. Following the transaction, the chief financial officer now directly owns 29,723 shares of the company’s stock, valued at $6,539,060. The disclosure for this sale can be found here. Company insiders own 13.60% of the company’s stock.
TRADEMARK VIOLATION NOTICE: “The Manufacturers Life Insurance Company Increases Stake in ICU Medical, Incorporated (ICUI)” was posted by The Ledger Gazette and is the property of of The Ledger Gazette. If you are reading this piece on another site, it was illegally stolen and reposted in violation of US & international trademark and copyright laws. The original version of this piece can be read at https://ledgergazette.com/2018/03/15/the-manufacturers-life-insurance-company-increases-stake-in-icu-medical-incorporated-icui.html.
ICU Medical Profile
ICU Medical, Inc is engaged in the development, manufacture and sales of medical devices used in infusion therapy, oncology and critical care applications. The Company’s product line includes needlefree connection devices, custom infusion sets, closed system transfer devices (CSTD) for the handling of hazardous drugs, advanced sensor catheters, needlefree closed blood sampling systems, disposable pressure transducer systems and hemodynamic monitoring systems.
Want to see what other hedge funds are holding ICUI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ICU Medical, Incorporated (NASDAQ:ICUI).
Receive News & Ratings for ICU Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical and related companies with MarketBeat.com's FREE daily email newsletter.